Abreu, A.d.J.L.d.; Mpande, C.A.M.; Helble, M.; Nicholson, M.W.; Cortés, M.d.l.Á.; Ponsa, M.E.P.; Blumenthal, I.R.; Caccavo, F.; Pippo, T.; Rius Sanjuan, J.;
et al. Investment Opportunities for mRNA Technology in Low- and Middle-Income Countries: Key Findings and Future Perspectives. Vaccines 2025, 13, 112.
https://doi.org/10.3390/vaccines13020112
AMA Style
Abreu AdJLd, Mpande CAM, Helble M, Nicholson MW, Cortés MdlÁ, Ponsa MEP, Blumenthal IR, Caccavo F, Pippo T, Rius Sanjuan J,
et al. Investment Opportunities for mRNA Technology in Low- and Middle-Income Countries: Key Findings and Future Perspectives. Vaccines. 2025; 13(2):112.
https://doi.org/10.3390/vaccines13020112
Chicago/Turabian Style
Abreu, Ariane de Jesus Lopes de, Cheleka A. M. Mpande, Matthias Helble, Martin W. Nicholson, María de los Ángeles Cortés, María Eugenia Pérez Ponsa, Ivan Redini Blumenthal, Francisco Caccavo, Tomas Pippo, Judit Rius Sanjuan,
and et al. 2025. "Investment Opportunities for mRNA Technology in Low- and Middle-Income Countries: Key Findings and Future Perspectives" Vaccines 13, no. 2: 112.
https://doi.org/10.3390/vaccines13020112
APA Style
Abreu, A. d. J. L. d., Mpande, C. A. M., Helble, M., Nicholson, M. W., Cortés, M. d. l. Á., Ponsa, M. E. P., Blumenthal, I. R., Caccavo, F., Pippo, T., Rius Sanjuan, J., & Nannei, C.
(2025). Investment Opportunities for mRNA Technology in Low- and Middle-Income Countries: Key Findings and Future Perspectives. Vaccines, 13(2), 112.
https://doi.org/10.3390/vaccines13020112
